Regulation of human T-cell leukemia virus type 1 gene expression by Sp1 and Sp3 interaction with TRE-1 repeat III

DNA and Cell Biology

Volumn 25, Issue 5, 2006, Pages 262-276

  Yao, Jing ^a   Grant, Christian ^a   Harhaj, Edward ^b   Nonnemacher, Michael ^a,c   Alefantis, Timothy ^d   Martin, Joel ^a   Jain, Pooja ^c   Wigdahl, Brian ^c  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d Vital Probles Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; TAX PROTEIN; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3;

ARTICLE; CD4+ T LYMPHOCYTE; CHROMATIN IMMUNOPRECIPITATION; DNA PROBE; DNA STRUCTURE; GENE EXPRESSION REGULATION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS; HUMAN T CELL LEUKEMIA VIRUS 1; LONG TERMINAL REPEAT; NONHUMAN; PRIORITY JOURNAL; TAX RESPONSIVE ELEMENT 1 REPEAT III; TRANSCRIPTION REGULATION;

CELL LINE; CHROMATIN IMMUNOPRECIPITATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION, VIRAL; GENES, VIRAL; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; PROTEIN BINDING; REPETITIVE SEQUENCES, NUCLEIC ACID; SP1 TRANSCRIPTION FACTOR; SP3 TRANSCRIPTION FACTOR; TRANS-ACTIVATION (GENETICS);

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 33744827709     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2006.25.262     Document Type: Article

References (64)

1. ARMSTRONG, A.P., FRANKLIN, A.A., UITTENBOGAARD, M.N., GIEBLER, H.A., and NYBORG, J.K. (1993). Pleiotropic effect of the human T-cell leukemia virus Tax protein on the DNA binding activity of eukaryotic transcription factors. Proc. Natl. Acad. Sci. USA 90, 7303-7307.
2. BANGHAM, C.R. (2003). The immune control and cell-to-cell spread of human T-lymphotropic virus type 1. J. Gen. Virol. 84, 3177-3189.
3. BARMAK, K., HARHAJ, E.W., GRANT, C., ALEFANTIS, T., and WIGDAHL, B. (2003). Human T cell leukemia virus type I-induced disease: Pathways to cancer and neurodegradation. Virology 308, 1-12.
4. BARNHART, M.K., CONNOR, L.M., and MARRIOTT, S.J. (1997). Function of the human T-cell leukemia virus type 1 21-base-pair repeats in basal transcription. J. Virol. 71, 337-344.
5. BILLON, N., CARLISI, D., DATTO, M.B., VAN GRUNSVEN, L.A., WATT, A., WANG, X.F., and RUDKIN, B.B. (1999). Cooperation of Sp1 and p300 in the induction of the CDK inhibitor p21WAF1/CIP1 during NGF-mediated neuronal differentiation. Oncogene 18, 2872-2882.
6. BLACK, A.R., BLACK, J.D., and AZIZKHAN-CLIFFORD, J. (2001). Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer. J. Cell. Physiol. 188, 143-160.
7. BOSSELUT, R., DUVALL, J.F., GEGONNE, A., BAILLY, M., HEMAR, A., BRADY, J., and GHYSDAEL, J. (1990). The product of the c-ets-1 proto-oncogene and the related Ets2 protein act as transcriptional activators of the long terminal repeat of human T cell leukemia virus HTLV-1. EMBO. J. 9, 3137-3144.
8. BRAUN, H., KOOP, R., ERTMER, A., NACHT, S., and SUSKE, G. (2001). Transcription factor Sp3 is regulated by acetylation. Nucleic Acids. Res. 29, 4994-5000.
9. COUREY, A.J., and TJIAN, R. (1988). Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif. Cell 55, 887-898.
10. DIGNAM, J.D., LEBOVITZ, R.M., and ROEDER, R.G. (1983). Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids. Res. 11, 1475-1489.
11. DITTMER, J., PISE-MASISON, C.A., CLEMENS, K.E., CHOI, K.S., and BRADY, J. (1997). Interaction of human T-cell lymphotropic virus type I Tax, Ets1, and Sp1 in transactivation of the PTHrP P2 promoter. J. Biol. Chem. 272, 4953-4958.
12. FOX, R.J., LEVIN, M.C., and JACOBSON, S. (1996). Tumor necrosis factor alpha expression in the spinal cord of human T-cell lymphotrophic virus type I associated myelopathy/tropical spastic paraparesis patients. J. Neurovirol. 2, 323-329.
13. FUJII, M., TSUCHIYA, H., MENG, X.B., and SEIKI, M. (1995). c-Jun, c-Fos and their family members activate the transcription mediated by three 21-bp repetitive sequences in the HTLV-1 long terminal repeat. Intervirology. 38, 221-228.
14. GEGONNE, A., BOSSELUT, R., BAILLY, R.A., and GHYSDAEL, J. (1993). Synergistic activation of the HTLV1 LTR Ets-responsive region by transcription factors Ets1 and Sp1. EMBO. J. 12, 1169-1178.
15. GESSAIN, A., BARIN, F., VERNANT, J.C., GOUT, O., MAURS, L., CALENDER, A., and DE THE, G. (1985). Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2, 407-410.
16. GIAM, C.Z., and XU, Y.L. (1989). HTLV-1 tax gene product activates transcription via pre-existing cellular factors and cAMP responsive element. J. Biol. Chem. 264, 15236-15241.
17. GRANT, C., BARMAK, K., ALEFANTIS. T., YAO, J., JACOBSON, S., and WIGDAHL, B. (2002). Human T cell leukemia virus type I and neurologic disease: Events in bone marrow, peripheral blood, and central nervous system during normal immune surveillance and neuroinflammation. J. Cell. Physiol. 190, 133-159.
18. HAGEN, G., MULLER, S., BEATO, M., and SUSKE, G. (1994). Sp1-mediated transcriptional activation is repressed by Sp3. EMBO. J. 13, 3843-3851.
19. HARROD, R., TANG, Y., NICOT, C., LU, H.S., VASSILEV, A., NAKATANI, Y., and GIAM, C.Z. (1998). An exposed KID-like domain in human T-cell lymphotropic virus type 1 Tax is responsible for the recruitment of coactivators CBP/p300. Mol. Cell. Biol. 18, 5052-5061.
20. HINUMA, Y., NAGATA, K., HANAOKA, M., NAKAI, M., MATSUMOTO, T., KINOSHITA, K.I., SHIRAKAWA, S., and MIYOSHI, I. (1981). Adult T-cell leukemia: Antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc. Natl. Acad. Sci. USA 78, 6476-6480.
21. HOGAN, T.H., STAUFF, D.L., KREBS, F.C., GARTNER, S., QUITERIO, S.J., and WIGDAHL, B. (2003). Structural and functional evolution of human immunodeficiency virus type 1 long terminal repeat CCAAT/enhancer binding protein sites and their use as molecular markers for central nervous system disease progression. J. Neurovirol. 9, 55-68.
22. KADONAGA, J.T., COUREY, A.J., LADIKA, J., and TJIAN, R. (1988). Distinct regions of SpI modulate DNA binding and transcriptional activation. Science 242, 1566-1570.
23. KASHANCHI, F., DUVALL, J.F., LINDHOLM, P.F., RADONOVICH, M.F., and BRADY, J.N. (1993). Sequences downstream of the RNA initiation site regulate human T-cell lymphotropic virus type I basal gene expression. J. Virol. 67, 2894-2902.
24. KASHANCHI, F., DUVALL, J.F., DITTMER, J., MIRESKANDARI, A., REID, R.L., GITLIN, S.D., and BRADY, J.N. (1994). Involvement of transcription factor YB-1 in human T-cell lymphotropic virus type I basal gene expression. J. Virol. 68, 561-565.
25. KENNETT, S.B., UDVADIA, A.J., and HOROWITZ, J.M. (1997). Sp3 encodes multiple proteins that differ in their capacity to stimulate or repress transcription. Nucleic Acids Res. 25, 3110-3117.
26. KENNETT, S.B., MOOREFIELD, K.S., and HOROWITZ, J.M. (2002). Sp3 represses gene expression via the titration of promoter-specific transcription factors. J. Biol. Chem. 277, 9780-9789.
27. KIMZEY, A.L., and DYNAN, W.S. (1998). Specific regions of contact between human T-cell leukemia virus type I Tax protein and DNA identified by photocross-linking. J. Biol. Chem. 273, 13768-13775.
28. KIMZEY, A.L., and DYNAN, W.S. (1999). Identification of a human T-cell leukemia virus type I tax peptide in contact with DNA. J. Biol. Chem. 274, 34226-34232.
29. KOYANAGI, Y., ITOYAMA, Y., NAKAMURA, N., TAKAMATSU, K., KIRA, J., IWAMASA, T., GOTO, I., and YAMAMOTO, N. (1993). In vivo infection of human T-cell leukemia virus type I in non-T cells. Virology 196, 25-33.
30. LANGMANN, T., BUCHER, C., RIES, S., SCHAEFFLER, A., ASLANIDIS, C., SCHUIERER, M., WEILER, M., SANDHOFF, K., DE JONG, P.J., and SCHMITZ, G. (1999). Transcription factors Sp1 and AP-2 mediate induction of acid sphingomyelinase during monocytic differentiation. J. Lipid. Res. 40, 870-880.
31. LEMASSON, I., POLAKOWSKI, N., LAYBOURN, P.J., and NYBORG, J.K. (2002). Transcription factor binding and histone modification on the integrated proviral promoter in HTLV-I-infected T-cells. J. Biol. Chem. 277, 49459-49465.
32. LENZMEIER, B.A., GIEBLER, H.A., and NYBORG, J.K. (1998). Human T-cell leukemia virus type 1 Tax requires direct access to DNA for recruitment of CREB binding protein to the viral promoter. Mol. Cell. Biol. 18, 721-731.
33. LIU, Z., and SIMPSON, E.R. (1999). Molecular mechanism for cooperation between Sp1 and steroidogenic factor-1 (SF-1) to regulate bovine CYP11A gene expression. Mol. Cell. Endocrinol. 153, 183-196.
34. LIVENGOOD, J.A., and NYBORG, J.K. (2004). The high-affinity Sp1 binding site in the HTLV-1 promoter contributes to Tax-independent basal expression. Nucleic Acids Res. 32, 2829-2837.
35. LOPEZ-RODRIGUEZ, C., BOTELLA, L., and CORBI, A.L. (1997). CCAAT-enhancer-binding proteins (C/EBP) regulate the tissue specific activity of the CD11c integrin gene promoter through functional interactions with Sp1 proteins. J. Biol. Chem. 272, 29120-29126.
36. MACATONIA, S.E., CRUICKSHANK, J.K., RUDGE, P., and KNIGHT, S.C. (1992). Dendritic cells from patients with tropical spastic paraparesis are infected with HTLV-1 and stimulate autologous lymphocyte proliferation. AIDS. Res. Hum. Retroviruses. 8, 1699-1706.
37. MAKINO, M., SHIMOKUBO, S., WAKAMATSU, S.I., IZUMO, S., and BABA, M. (1999). The role of human T-lymphotropic virus type 1 (HTLV-1)-infected dendritic cells in the development of HTLV-1-associated myelopathy/tropical spastic paraparesis. J. Virol. 73, 4575-4581.
38. NYBORG, J.K., DYNAN, W.S., CHEN, I.S., and WACHSMAN, W. (1988). Binding of host-cell factors to DNA sequences in the long terminal repeat of human T-cell leukemia virus type I: Implications for viral gene expression. Proc. Natl. Acad. Sci. USA 85, 1457-1461.
39. OKUMURA, K., SAKAGUCHI, G., TAKAGI, S., NAITO, K., MIMORI, T., and IGARASHI, H. (1996). Sp1 family proteins recognize the U5 repressive element of the long terminal repeat of human T cell leukemia virus type I through binding to the CACCC core motif. J. Biol. Chem. 271, 12944-12950.
40. OSAME, M., USUKU, K., IZUMO, S., IJICHI, N., AMITANI, H., IGATA, A., MATSUMOTO, M., and TARA, M. (1986). HTLV-I associated myelopathy, a new clinical entity. Lancet 1, 1031-1032.
41. PACA-UCCARALERTKUN, S., ZHAO, L.J., ADYA, N., CROSS, J.V., CULLEN, B.R., BOROS, I.M., and GIAM, C.Z. (1994). In vitro selection of DNA elements highly responsive to the human T-cell lymphotropic virus type I transcriptional activator, Tax. Mol. Cell. Biol. 14, 456-462.
42. PERKINS, N.D., EDWARDS, N.L., DUCKETT, C.S., AGRANOFF, A.B., SCHMID, K.M., and NABEL, G.J. (1993). A cooperative interaction between NF-kB and Sp1 is required for HIV-1 enhancer activation. EMBO. J. 12, 3551-3558.
43. POIESZ, B.J., RUSCETTI, F.W., GAZDAR, A.F., BUNN, P.A., MINNA, J.D., and GALLO, R.C. (1980). Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA 77, 7415-7419.
44. RIES, S., BUCHER, C., LANGMANN, T., FEHRINGER, P., ASLANIDIS, C., and SCHMITZ, G. (1998). Transcriptional regulation of lysosomal acid lipase in differentiating monocytes is mediated by transcription factors Sp1 and AP-2. J. Lipid Res. 39, 2125-2134.
45. ROHR, O., MARBAN, C., AUNIS, D., and SCHAEFFER, E. (2003). Regulation of HIV-1 gene transcription: From lymphocytes to microglial cells. J. Leukoc. Biol. 74, 736-749.
46. ROSS, H.L., GARTNER, S., MCARTHUR, J.C., CORBOY, J.R., MCALLISTER, J.J., MILLHOUSE, S., and WIGDAHL, B. (2001). HIV-1 LTR C/EBP binding site sequence configurations preferentially encountered in brain lead to enhanced C/EBP factor binding and increased LTR-specific activity. J. Neurovirol. 7, 235-249.
47. SAFFER, J.D., JACKSON, S.P., and ANNARELLA, M.B. (1990). Developmental expression of Sp1 in the mouse. Mol. Cell. Biol. 11, 2189-2199.
48. SCHWARTZ, C., CATEZ, P., ROHR, O., LECESTRE, D., AUNIS, D., and SCHAEFFER, E. (2000). Functional interactions between C/EBP, Sp1, and COUP-TF regulate human immunodeficiency virus type 1 gene transcription in human brian cells. J. Virol. 74, 65-73.
49. SEELER, J.S., MUCHARDT, C., PODAR, M., and GAYNOR, R.B. (1993). Regulatory elements involved in tax-mediated transactivation of the HTLV-I LTR. Virology 196, 442-450.
50. SUSKE, G. (1999). The Sp-family of transcription factors. Gene 238, 291-300.
51. TANIMURA, A., TESHIMA, H., FUJISAWA, J., and YOSHIDA, M. (1993). A new regulatory clement that augments the Tax-dependent enhancer of human T-cell leukemia virus type 1 and cloning of cDNAs encoding its binding proteins. J. Virol. 67, 5375-5382.
52. TILLMANN, M., WESSNER, R., and WIGDAHL, B. (1994). Identification of human T-cell lymphotropic virus type 1 21-base-pair repeat-specific and glial cell-specific DNA-protein complexes. J. Virol. 68, 4597-4608.
53. TORGEMAN, A., MOR-VAKNIN, N., and ABOUD, M. (1999). Sp1 is involved in a protein kinase C-independcnt activation of human T cell leukemia virus type 1 long terminal repeat by 12-O-tetradecanoylphorbol-13-acetate. Virology 254, 279-287.
54. TORGEMAN, A., MOR-VAKNIN, N., ZELIN, E., BEN-AROYA, Z., LOCHELT, M., FLUGEL, R.M., and ABOUD, M. (2001). Sp1-p53 heterocomplex mediates activation of HTLV-I long terminal repeat by l2-O-tetradecanoylphorbol-13-acetate that is antagonized by protein kinase C. Virology 281, 10-20.
55. VO, N., and GOODMAN, R.H. (2001). CREB-binding protein and p300 in transeriptional regulation. J. Biol. Chem. 276, 13505-13508.
56. WESSNER, R., and WIGDAHL, B. (1997a). AP-1 derived from mature monocytes and astrocytes preferentially interacts with the HTLV-I promoter central 21 bp repeat. Leukemia 11(Suppl 3), 21-24.
57. WESSNER, R., TILLMANN-BOGUSH, M., and WIGDAHL, B. (1995). Characterization of a glial cell-specific DNA-protein complex formed with the human T cell lymphotropic virus type 1 (HTLV-I) enhancer. J. Neurovirol. 1, 62-77.
58. WESSNER, R., YAO, J., and WIGDAHL, B. (1997). Sp family members preferentially interact with the promoter proximal repeat within the HTLV-I enhancer. Leukemia 11(Suppl 3), 10-13.
59. WIGDAHL, B., and BRADY, J. (1996). Molecular aspects of HTLV-I: Relationship to neurological diseases. J. Neurovirol. 2, 307-322.
60. YAN, J.P., GARRUS, J.E., GlEBLER, H.A., STARGELL, L.A., and NYBORG, J.K. (1998). Molecular interactions between the coactivator CBP and the human T-cell leukemia virus Tax protein. J. Mol. Biol. 281, 395-400.
61. YAO, J., and WIGDAHL, B. (2000). Human T cell lymphotropic virus type 1 genomic expression and impact on intracellular signaling pathways during neurodegenerative disease and leukemia. Front. Biosci. 5, D138-D168.
62. YOSHIDA, M., SEIKI, M., YAMAGUCHI, K., and TAKATSUKI, K. (1984). Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc. Natl. Acad. Sci. USA 81, 2534-2537.
63. ZAID, A., HODNY, Z., LI, R., and NELSON, B.D. (2001). Sp1 acts as a repressor of the human adenine nucleotide translocase-2 (ANT2) promoter. Eur. J. Biochem. 268, 5497-5503.
64. ZHAO, L.J., and GIAM, C.Z. (1992). Human T-cell lymphotropic virus type I (HTLV-I) transcriptional activator, Tax, enhances CREB binding to HTLV-1 21-base-pair repeats by protein-protein interaction. Proc. Natl. Acad. Sci. USA 89, 7070-7074.